Significant treatment revenues generated for the first time, roll-out in Europe and Germany to be continued; Approval for prostate treatment expected in 2021 In the first six months of 2020, MagForce AG treated a significant number of glioblastoma patients for the first time. By treating 11 patients in Germany and six patients in Poland, the com [ … ]

MagForce AG Publishes Financial Results for the First Half of 2020 and Operative Highlights   - Very significant increase in European patient inquiries for NanoTherm therapy system for the treatment of glioblastomas - U.S. focal prostate cancer treatment study: positive findings of Stage 1 confirmed during current Stage - positive treatment resul [ … ]

DGAP-Media / 20.10.2020 / 09:50 MagForce AG: 'NanoTherm School' successfully enters the third round with 'Module B - Part II' - MagForce successfully hosted the third session of the practice-oriented, unique and multifaceted application training series for the use of the NanoTherm therapy system for the treatment of glioblastoma. - The Nan [ … ]

In its current letter to shareholders, MagForce AG reports a sustained positive development in the number of treatments for brain tumor patients (glioblastoma) in Europe. After the preparatory work for the commercialization of the MagForce technology has been completed in recent years, significant treatment revenues are expected to be generated fo [ … ]

MagForce AG Publishes Shareholder Letter Europe: Continued significantly increased numbers of brain tumor treatments USA: Treatments of patients in current stage of the prostate cancer trial with streamlined protocol so far show only minimal treatment-related side effects Berlin, Germany, and Nevada, USA, September 21, 2020 - MagForce AG (Frankf [ … ]

MagForce AG announces positive results of 2020 Annual General Meeting Berlin, Germany, and Nevada, USA, August 13, 2020 - MagForce AG (Frankfurt, Scale, Xetra: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, held its Annual General Meeting today in a virtual setting. The Annual General M [ … ]